Treatment of vasculitis with IL-6 antagonist
US8617550B2 · kind B2 · utility
17Cited by
11References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2004 |
| Grant date | Dec 31, 2013 |
| Priority date | — |
| Expiry date | Sep 11, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
To provide a preventive and/or therapeutic agent for vasculitis such as polyarteritis nodosa, the aortitis syndrome, and a vasculitis that is associated with immunological abnormalities, said agent comprising an interleukin-6 (IL-6) antagonist as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.